An AI-powered diabetes prevention app performs as well as a human-led program in achieving weight loss, A1c reduction, and ...

Novo Nordisk reported promising mid-stage results for its experimental obesity drug amycretin in diabetes patients on Tuesday ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Healthy weight loss is all about finding the right balance between exercise and eating healthy, and a weight loss program can help you do that as you work to reach your health goals. However, it can ...

The Hampton Roads Show airs weekdays at 11 a.m. on WAVY-TV 10.

Health care leaders and professionals constantly seek ways to improve their clients’ lifestyles. In recent times, nutritional programs have emerged as a tool that provides a balanced diet to drive ...

Get the skinny on getting skinny. — -- Just in time for swimsuit season, a new study has come out saying there's very little scientific evidence to prove most diet and weight-loss regimens ...

Costco and its low-cost health care partner are expanding into weight-loss management. Costco will begin offering its members in the U.S. access to a weight loss program through Sesame, a health care ...

Being overweight can sometimes impact your mental and physical health, which may lead you to look for healthy weight loss paths. But with so many options out there, it can be confusing to know which ...

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...